Objective: To establish the diagnostic concentration range of urine cystatin C and the control level of urine cystatin C for patients with renal injury, and to help promote the establishment of standardization of urine cystatin C detection. Methods: 150 urine specimens and blood specimens from kidney injury patients and healthy people were collected, and stored in the refrigerator at -80°C for later use. After the specimens were collected, they were uniformly tested. Comparing the difference of blood and urine cystatin C between the kidney injury group and the healthy control group, the application value of urine cystatin C in the diagnosis and treatment of kidney injury was put forward. Results: The concentrations of cystatin C in urine and blood of renal injury group were 1.04 ± 2.14 mg/L and 1.94 ± 2.36 mg/L respectively; the concentrations of cystatin C in urine and blood of healthy control group were 0.11 ± 0.05 mg/L and 0.83 ± 0.20 mg/L respectively. The urine and blood cystatin C of the kidney injury group were significantly higher than those of the healthy control group. Compared the results of the two groups, the t values were 5.3210 and 5.7399, respectively. The P value is 0.0000; the difference is statistically significant; in comparison of urine and blood cystatin C in the kidney injury group, the value is that t = 3.4600, P = 0.0003; in comparison of urine and blood cystatin C in the healthy control group, the value is that t = 42.7744, P = 0.0000. By investigating the urine cystatin C concentration of patients with kidney injury, whether it is kidney injury or healthy controls, urine cystatin C is significantly lower than blood cystatin C. Conclusion: According to the results of this study, the concentration of urinary cystatin C in the healthy control group is 0.11 ± 0.05 mg/L. The reference interval of urinary cystatin C proposed in this study is 0.06 - 0.16 mg/L, which can be established by comprehensive multi center research. Through a multi-center study of the baseline level of urinary cystatin C in patients with renal injury, the diagnostic concentration interval of urinary cystatin C and the control level of urine cystatin C for renal injury patients were established.
References
[1]
Xu, Q. (2020) The Predictive Value of Cystatin C in the Early Diagnosis of Diabetic Nephropathy. Jilin University, Jilin.
[2]
Xie, S.Q., Gong, M., Liu, W., et al. (2019) The Clinical Significance of Serum Cystatin C and Urine Renal Injury Molecule-1 in Patients with Early Renal Injury in Hypertensive Disorders of Pregnancy. Experimental and Laboratory Medicine, 37, 356-357+371.
[3]
Chen, S.P. (2021) The Diagnostic Value of Serum Cystatin C and Urine Renal Damage Molecule-1 in the Diagnosis of Early Renal Injury in Patients with Hypertension in Pregnancy. China Maternal and Child Health Care, 36, 555-557.
[4]
Fan, L.J., Lu, T.J. and Cui, Y.J. (2019) Urine Complement Factor D Combined with Serum Cystatin C to Predict the Value of Severe Preeclampsia Renal Injury. China Journal of Modern Medicine, 29, 113-116.
[5]
Wang, G.Q., Yang, L.H., Cheng, X., et al. (2018) The Diagnostic Value of Urine Microprotein, Cystatin C and Urine Routine Tests for Early Renal Function Damage in Patients with Hyperbilirubinemia. Journal of Modern Laboratory Medicine, 33, 70-73.
[6]
Chen, Y.P., Huang, L. and Wu, J.Q. (2018) The Evaluation Significance of Serum Cystatin C and Urine Kidney Injury Molecule 1 Levels on the Degree of Renal Tubulointerstitial Injury in Hypertension. Clinical Medical Engineering, 25, 1077-1078.
[7]
Wang, B. (2018) To Explore the Clinical Value of Combined Detection of Urinary Microalbumin/Creatinine and Cystatin C in the Early Diagnosis of Diabetic Nephropathy. Medical Treatment, No. 1, 73.
[8]
Huang, L.L., Miao, H.J., Lu, Y., et al. (2017) Changes in Serum Cystatin C and Urine Renal Injury Molecule 1 Levels in Patients with Sepsis and Their Diagnostic Value for Complicated Acute Kidney Injury. Shandong Medicine, 57, 70-72.
[9]
Wang, H., Lu, Y., Gu, Y.J., et al. (2017) Establishment and Evaluation of the Detection Limit and Quantification Limit of Urine Cystatin C with Conventional Cystatin C Reagent Based on EP17-A Document. Shanxi Medical Journal, 46, 1224-1226.
[10]
Zhou, W. and Zhou, L.L. (2021) The Clinical Value of Urine Cystatin C Combined with Serum β_2 Microglobulin Level in the Diagnosis of Patients with Lupus Nephritis. Labeled Immunoassay and Clinic, 28, 1185-1187+1221.
[11]
Zeng, Y., Zhang, L., Shen, H., et al. (2019) The Clinical Value of Serum Homocysteine, Cystatin C, Urine Albumin, and Urine β_2 Microglobulin Levels on Diabetic Nephropathy. Journal of Practical Clinical Medicine, 23, 109-112.
[12]
Li, Z.Q. and Li, H.B. (2019) Analysis of the Diagnostic Value of Serum Cystatin C Combined with Urine α1-MG and mALB in the Diagnosis of Early Renal Damage in Chronic Nephritis. Harbin Medicine, 39, 304-306.
